HQL ETF
Holdings131
HQL ETF
abrdn Life Sciences Investors
Holdings131
HQL ETF Top Holdings
HQL holdings top 10 positions. The top 10 holdings account for 43.4% of the fund, led by Regeneron Pharmaceuticals Inc at 7.4%, Amgen Inc at 7.3%, Gilead Sciences Inc at 6.6%.
HQL portfolio concentration is moderate, with the top 10 representing 43.4% of total assets.
HQL sector allocation provides a detailed breakdown. HQL overlap tool shows how holdings compare to other funds in your portfolio.








